SCHEMBL5224464

SCHEMBL5224464

C1=CN(C2CCN(c3ccccn3)CC2)CN1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PLD1 Q13393 1/20 0.49
CHI3L1 P36222 1/20 0.43
GPR119 Q8TDV5 2/20 0.43
MEN1 O00255 1/20 0.43
USP2 O75604 1/20 0.43
ALDH1A1 P00352 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
MAPK1 P28482 1/20 0.43
CYP2C19 P33261 1/20 0.43
KMT2A Q03164 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HSD17B10 Q99714 1/20 0.43
KDM4E B2RXH2 2/20 0.42
AVPR1A P37288 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28173370 0.73 HRH3 (0.57) PLD1KDM4E
SCHEMBL28101766 0.72 HRH3 (0.56) PLD1
SCHEMBL15800694 0.71 PLD1 (0.73) PLD1MEN1USP2ALDH1A1CYP3A4
SCHEMBL21353591 0.71
SCHEMBL29857922 0.71 PLD1 (0.73) PLD1MEN1USP2ALDH1A1CYP3A4
SCHEMBL6499166 0.71 PLD1 (0.44) PLD1MEN1USP2ALDH1A1CYP3A4
SCHEMBL243658 0.71 PLD1 (0.58) PLD1GPR119MEN1USP2ALDH1A1
SCHEMBL1245662 0.71 PLD1 (0.58) PLD1CHI3L1GPR119ALDH1A1SMN1; SMN2
SCHEMBL29683564 0.71 PLD1 (0.58) PLD1GPR119MEN1USP2ALDH1A1
SCHEMBL359401 0.71 PLD1 (0.58) PLD1GPR119MEN1ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1841768-A1 PURINE DERIVATIVES ACTING AS A2A RECEPTOR AGONISTS Novartis AG (CH) 2007-10-10 EP disclosed
WO-2006074925-A1 PURINE DERIVATIVES ACTING AS A2A RECEPTOR AGONISTS NOVARTIS AG (CH) 2006-07-20 WO disclosed